Researchers report on how intranasal medications can be better absorbed and could provide more effective treatments for neurological diseases.
New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.
Researchers discover proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as a target for new therapies.
Future research into the underlying causes of neurological disorders such as autism, epilepsy and schizophrenia, should greatly benefit from a first-of-its-kind atlas of gene-enhancers in the cerebrum (telencephalon). This new atlas identifies and locates thousands of gene-regulating elements in a region of the brain that is of critical importance for cognition, motor functions and emotion.
Scientists report researchers are now on the threshold of human application of stem cell therapies for a class of neurological diseases known as myelin disorders – a long list of diseases that include conditions such as multiple sclerosis, white matter stroke, cerebral palsy, certain dementias, and rare but fatal childhood disorders called pediatric leukodystrophies.
UCLA researchers have combined two tools — gene expression and the use of peripheral blood — to expand scientists’ arsenal...
Communication errors between brain cells may lead to neurodegenerative diseases such as Parkinson’s Patrik Verstreken (VIB/K.U.Leuven) has discovered the mechanism...
